Global Computational Medicine and Drug Designing Software Market Insights, Forecast to 2028

Report ID: 1637905 | Published Date: Jan 2025 | No. of Page: 111 | Base Year: 2024 | Rating: 4.8 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Computational Medicine and Drug Designing Software Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Cloud-based
        1.2.3 On-premise
    1.3 Market by Application
        1.3.1 Global Computational Medicine and Drug Designing Software Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Drug Discovery and Development
        1.3.3 Computational Physiological Medicine
        1.3.4 Disease Modeling
        1.3.5 Medical Imaging
        1.3.6 Predictive Analysis of Drug Targets
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Computational Medicine and Drug Designing Software Market Perspective (2017-2028)
    2.2 Computational Medicine and Drug Designing Software Growth Trends by Region
        2.2.1 Computational Medicine and Drug Designing Software Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Computational Medicine and Drug Designing Software Historic Market Size by Region (2017-2022)
        2.2.3 Computational Medicine and Drug Designing Software Forecasted Market Size by Region (2023-2028)
    2.3 Computational Medicine and Drug Designing Software Market Dynamics
        2.3.1 Computational Medicine and Drug Designing Software Industry Trends
        2.3.2 Computational Medicine and Drug Designing Software Market Drivers
        2.3.3 Computational Medicine and Drug Designing Software Market Challenges
        2.3.4 Computational Medicine and Drug Designing Software Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Computational Medicine and Drug Designing Software Players by Revenue
        3.1.1 Global Top Computational Medicine and Drug Designing Software Players by Revenue (2017-2022)
        3.1.2 Global Computational Medicine and Drug Designing Software Revenue Market Share by Players (2017-2022)
    3.2 Global Computational Medicine and Drug Designing Software Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Computational Medicine and Drug Designing Software Revenue
    3.4 Global Computational Medicine and Drug Designing Software Market Concentration Ratio
        3.4.1 Global Computational Medicine and Drug Designing Software Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Computational Medicine and Drug Designing Software Revenue in 2021
    3.5 Computational Medicine and Drug Designing Software Key Players Head office and Area Served
    3.6 Key Players Computational Medicine and Drug Designing Software Product Solution and Service
    3.7 Date of Enter into Computational Medicine and Drug Designing Software Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Computational Medicine and Drug Designing Software Breakdown Data by Type
    4.1 Global Computational Medicine and Drug Designing Software Historic Market Size by Type (2017-2022)
    4.2 Global Computational Medicine and Drug Designing Software Forecasted Market Size by Type (2023-2028)
5 Computational Medicine and Drug Designing Software Breakdown Data by Application
    5.1 Global Computational Medicine and Drug Designing Software Historic Market Size by Application (2017-2022)
    5.2 Global Computational Medicine and Drug Designing Software Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Computational Medicine and Drug Designing Software Market Size (2017-2028)
    6.2 North America Computational Medicine and Drug Designing Software Market Size by Type
        6.2.1 North America Computational Medicine and Drug Designing Software Market Size by Type (2017-2022)
        6.2.2 North America Computational Medicine and Drug Designing Software Market Size by Type (2023-2028)
        6.2.3 North America Computational Medicine and Drug Designing Software Market Share by Type (2017-2028)
    6.3 North America Computational Medicine and Drug Designing Software Market Size by Application
        6.3.1 North America Computational Medicine and Drug Designing Software Market Size by Application (2017-2022)
        6.3.2 North America Computational Medicine and Drug Designing Software Market Size by Application (2023-2028)
        6.3.3 North America Computational Medicine and Drug Designing Software Market Share by Application (2017-2028)
    6.4 North America Computational Medicine and Drug Designing Software Market Size by Country
        6.4.1 North America Computational Medicine and Drug Designing Software Market Size by Country (2017-2022)
        6.4.2 North America Computational Medicine and Drug Designing Software Market Size by Country (2023-2028)
        6.4.3 United States
        6.4.4 Canada
7 Europe
    7.1 Europe Computational Medicine and Drug Designing Software Market Size (2017-2028)
    7.2 Europe Computational Medicine and Drug Designing Software Market Size by Type
        7.2.1 Europe Computational Medicine and Drug Designing Software Market Size by Type (2017-2022)
        7.2.2 Europe Computational Medicine and Drug Designing Software Market Size by Type (2023-2028)
        7.2.3 Europe Computational Medicine and Drug Designing Software Market Share by Type (2017-2028)
    7.3 Europe Computational Medicine and Drug Designing Software Market Size by Application
        7.3.1 Europe Computational Medicine and Drug Designing Software Market Size by Application (2017-2022)
        7.3.2 Europe Computational Medicine and Drug Designing Software Market Size by Application (2023-2028)
        7.3.3 Europe Computational Medicine and Drug Designing Software Market Share by Application (2017-2028)
    7.4 Europe Computational Medicine and Drug Designing Software Market Size by Country
        7.4.1 Europe Computational Medicine and Drug Designing Software Market Size by Country (2017-2022)
        7.4.2 Europe Computational Medicine and Drug Designing Software Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Computational Medicine and Drug Designing Software Market Size (2017-2028)
    8.2 Asia-Pacific Computational Medicine and Drug Designing Software Market Size by Type
        8.2.1 Asia-Pacific Computational Medicine and Drug Designing Software Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Computational Medicine and Drug Designing Software Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Computational Medicine and Drug Designing Software Market Share by Type (2017-2028)
    8.3 Asia-Pacific Computational Medicine and Drug Designing Software Market Size by Application
        8.3.1 Asia-Pacific Computational Medicine and Drug Designing Software Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Computational Medicine and Drug Designing Software Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Computational Medicine and Drug Designing Software Market Share by Application (2017-2028)
    8.4 Asia-Pacific Computational Medicine and Drug Designing Software Market Size by Region
        8.4.1 Asia-Pacific Computational Medicine and Drug Designing Software Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Computational Medicine and Drug Designing Software Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Computational Medicine and Drug Designing Software Market Size (2017-2028)
    9.2 Latin America Computational Medicine and Drug Designing Software Market Size by Type
        9.2.1 Latin America Computational Medicine and Drug Designing Software Market Size by Type (2017-2022)
        9.2.2 Latin America Computational Medicine and Drug Designing Software Market Size by Type (2023-2028)
        9.2.3 Latin America Computational Medicine and Drug Designing Software Market Share by Type (2017-2028)
    9.3 Latin America Computational Medicine and Drug Designing Software Market Size by Application
        9.3.1 Latin America Computational Medicine and Drug Designing Software Market Size by Application (2017-2022)
        9.3.2 Latin America Computational Medicine and Drug Designing Software Market Size by Application (2023-2028)
        9.3.3 Latin America Computational Medicine and Drug Designing Software Market Share by Application (2017-2028)
    9.4 Latin America Computational Medicine and Drug Designing Software Market Size by Country
        9.4.1 Latin America Computational Medicine and Drug Designing Software Market Size by Country (2017-2022)
        9.4.2 Latin America Computational Medicine and Drug Designing Software Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Computational Medicine and Drug Designing Software Market Size (2017-2028)
    10.2 Middle East & Africa Computational Medicine and Drug Designing Software Market Size by Type
        10.2.1 Middle East & Africa Computational Medicine and Drug Designing Software Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Computational Medicine and Drug Designing Software Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Computational Medicine and Drug Designing Software Market Share by Type (2017-2028)
    10.3 Middle East & Africa Computational Medicine and Drug Designing Software Market Size by Application
        10.3.1 Middle East & Africa Computational Medicine and Drug Designing Software Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Computational Medicine and Drug Designing Software Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Computational Medicine and Drug Designing Software Market Share by Application (2017-2028)
    10.4 Middle East & Africa Computational Medicine and Drug Designing Software Market Size by Country
        10.4.1 Middle East & Africa Computational Medicine and Drug Designing Software Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Computational Medicine and Drug Designing Software Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 Entelos
        11.1.1 Entelos Company Details
        11.1.2 Entelos Business Overview
        11.1.3 Entelos Computational Medicine and Drug Designing Software Introduction
        11.1.4 Entelos Revenue in Computational Medicine and Drug Designing Software Business (2017-2022)
        11.1.5 Entelos Recent Developments
    11.2 Crown Bioscience
        11.2.1 Crown Bioscience Company Details
        11.2.2 Crown Bioscience Business Overview
        11.2.3 Crown Bioscience Computational Medicine and Drug Designing Software Introduction
        11.2.4 Crown Bioscience Revenue in Computational Medicine and Drug Designing Software Business (2017-2022)
        11.2.5 Crown Bioscience Recent Developments
    11.3 Chemical Computing Group
        11.3.1 Chemical Computing Group Company Details
        11.3.2 Chemical Computing Group Business Overview
        11.3.3 Chemical Computing Group Computational Medicine and Drug Designing Software Introduction
        11.3.4 Chemical Computing Group Revenue in Computational Medicine and Drug Designing Software Business (2017-2022)
        11.3.5 Chemical Computing Group Recent Developments
    11.4 Nimbus Therapeutics
        11.4.1 Nimbus Therapeutics Company Details
        11.4.2 Nimbus Therapeutics Business Overview
        11.4.3 Nimbus Therapeutics Computational Medicine and Drug Designing Software Introduction
        11.4.4 Nimbus Therapeutics Revenue in Computational Medicine and Drug Designing Software Business (2017-2022)
        11.4.5 Nimbus Therapeutics Recent Developments
    11.5 Schrodinger
        11.5.1 Schrodinger Company Details
        11.5.2 Schrodinger Business Overview
        11.5.3 Schrodinger Computational Medicine and Drug Designing Software Introduction
        11.5.4 Schrodinger Revenue in Computational Medicine and Drug Designing Software Business (2017-2022)
        11.5.5 Schrodinger Recent Developments
    11.6 Dassault Systemes
        11.6.1 Dassault Systemes Company Details
        11.6.2 Dassault Systemes Business Overview
        11.6.3 Dassault Systemes Computational Medicine and Drug Designing Software Introduction
        11.6.4 Dassault Systemes Revenue in Computational Medicine and Drug Designing Software Business (2017-2022)
        11.6.5 Dassault Systemes Recent Developments
    11.7 Genedata
        11.7.1 Genedata Company Details
        11.7.2 Genedata Business Overview
        11.7.3 Genedata Computational Medicine and Drug Designing Software Introduction
        11.7.4 Genedata Revenue in Computational Medicine and Drug Designing Software Business (2017-2022)
        11.7.5 Genedata Recent Developments
    11.8 Biognos
        11.8.1 Biognos Company Details
        11.8.2 Biognos Business Overview
        11.8.3 Biognos Computational Medicine and Drug Designing Software Introduction
        11.8.4 Biognos Revenue in Computational Medicine and Drug Designing Software Business (2017-2022)
        11.8.5 Biognos Recent Developments
    11.9 Leadscope
        11.9.1 Leadscope Company Details
        11.9.2 Leadscope Business Overview
        11.9.3 Leadscope Computational Medicine and Drug Designing Software Introduction
        11.9.4 Leadscope Revenue in Computational Medicine and Drug Designing Software Business (2017-2022)
        11.9.5 Leadscope Recent Developments
    11.10 Rhenovia Pharma Limited
        11.10.1 Rhenovia Pharma Limited Company Details
        11.10.2 Rhenovia Pharma Limited Business Overview
        11.10.3 Rhenovia Pharma Limited Computational Medicine and Drug Designing Software Introduction
        11.10.4 Rhenovia Pharma Limited Revenue in Computational Medicine and Drug Designing Software Business (2017-2022)
        11.10.5 Rhenovia Pharma Limited Recent Developments
    11.11 Compugen
        11.11.1 Compugen Company Details
        11.11.2 Compugen Business Overview
        11.11.3 Compugen Computational Medicine and Drug Designing Software Introduction
        11.11.4 Compugen Revenue in Computational Medicine and Drug Designing Software Business (2017-2022)
        11.11.5 Compugen Recent Developments
    11.12 Certara LP
        11.12.1 Certara LP Company Details
        11.12.2 Certara LP Business Overview
        11.12.3 Certara LP Computational Medicine and Drug Designing Software Introduction
        11.12.4 Certara LP Revenue in Computational Medicine and Drug Designing Software Business (2017-2022)
        11.12.5 Certara LP Recent Developments
    11.13 Prosarix
        11.13.1 Prosarix Company Details
        11.13.2 Prosarix Business Overview
        11.13.3 Prosarix Computational Medicine and Drug Designing Software Introduction
        11.13.4 Prosarix Revenue in Computational Medicine and Drug Designing Software Business (2017-2022)
        11.13.5 Prosarix Recent Developments
    11.14 Simulations Plus
        11.14.1 Simulations Plus Company Details
        11.14.2 Simulations Plus Business Overview
        11.14.3 Simulations Plus Computational Medicine and Drug Designing Software Introduction
        11.14.4 Simulations Plus Revenue in Computational Medicine and Drug Designing Software Business (2017-2022)
        11.14.5 Simulations Plus Recent Developments
    11.15 Strand Life Sciences
        11.15.1 Strand Life Sciences Company Details
        11.15.2 Strand Life Sciences Business Overview
        11.15.3 Strand Life Sciences Computational Medicine and Drug Designing Software Introduction
        11.15.4 Strand Life Sciences Revenue in Computational Medicine and Drug Designing Software Business (2017-2022)
        11.15.5 Strand Life Sciences Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer

List of Tables
    Table 1. Global Computational Medicine and Drug Designing Software Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Cloud-based
    Table 3. Key Players of On-premise
    Table 4. Global Computational Medicine and Drug Designing Software Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 5. Global Computational Medicine and Drug Designing Software Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Computational Medicine and Drug Designing Software Market Size by Region (2017-2022) & (US$ Million)
    Table 7. Global Computational Medicine and Drug Designing Software Market Share by Region (2017-2022)
    Table 8. Global Computational Medicine and Drug Designing Software Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 9. Global Computational Medicine and Drug Designing Software Market Share by Region (2023-2028)
    Table 10. Computational Medicine and Drug Designing Software Market Trends
    Table 11. Computational Medicine and Drug Designing Software Market Drivers
    Table 12. Computational Medicine and Drug Designing Software Market Challenges
    Table 13. Computational Medicine and Drug Designing Software Market Restraints
    Table 14. Global Computational Medicine and Drug Designing Software Revenue by Players (2017-2022) & (US$ Million)
    Table 15. Global Computational Medicine and Drug Designing Software Revenue Share by Players (2017-2022)
    Table 16. Global Top Computational Medicine and Drug Designing Software by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Computational Medicine and Drug Designing Software as of 2021)
    Table 17. Ranking of Global Top Computational Medicine and Drug Designing Software Companies by Revenue (US$ Million) in 2021
    Table 18. Global 5 Largest Players Market Share by Computational Medicine and Drug Designing Software Revenue (CR5 and HHI) & (2017-2022)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Computational Medicine and Drug Designing Software Product Solution and Service
    Table 21. Date of Enter into Computational Medicine and Drug Designing Software Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Computational Medicine and Drug Designing Software Market Size by Type (2017-2022) & (US$ Million)
    Table 24. Global Computational Medicine and Drug Designing Software Revenue Market Share by Type (2017-2022)
    Table 25. Global Computational Medicine and Drug Designing Software Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 26. Global Computational Medicine and Drug Designing Software Revenue Market Share by Type (2023-2028)
    Table 27. Global Computational Medicine and Drug Designing Software Market Size by Application (2017-2022) & (US$ Million)
    Table 28. Global Computational Medicine and Drug Designing Software Revenue Share by Application (2017-2022)
    Table 29. Global Computational Medicine and Drug Designing Software Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 30. Global Computational Medicine and Drug Designing Software Revenue Share by Application (2023-2028)
    Table 31. North America Computational Medicine and Drug Designing Software Market Size by Type (2017-2022) & (US$ Million)
    Table 32. North America Computational Medicine and Drug Designing Software Market Size by Type (2023-2028) & (US$ Million)
    Table 33. North America Computational Medicine and Drug Designing Software Market Size by Application (2017-2022) & (US$ Million)
    Table 34. North America Computational Medicine and Drug Designing Software Market Size by Application (2023-2028) & (US$ Million)
    Table 35. North America Computational Medicine and Drug Designing Software Market Size by Country (2017-2022) & (US$ Million)
    Table 36. North America Computational Medicine and Drug Designing Software Market Size by Country (2023-2028) & (US$ Million)
    Table 37. Europe Computational Medicine and Drug Designing Software Market Size by Type (2017-2022) & (US$ Million)
    Table 38. Europe Computational Medicine and Drug Designing Software Market Size by Type (2023-2028) & (US$ Million)
    Table 39. Europe Computational Medicine and Drug Designing Software Market Size by Application (2017-2022) & (US$ Million)
    Table 40. Europe Computational Medicine and Drug Designing Software Market Size by Application (2023-2028) & (US$ Million)
    Table 41. Europe Computational Medicine and Drug Designing Software Market Size by Country (2017-2022) & (US$ Million)
    Table 42. Europe Computational Medicine and Drug Designing Software Market Size by Country (2023-2028) & (US$ Million)
    Table 43. Asia Pacific Computational Medicine and Drug Designing Software Market Size by Type (2017-2022) & (US$ Million)
    Table 44. Asia Pacific Computational Medicine and Drug Designing Software Market Size by Type (2023-2028) & (US$ Million)
    Table 45. Asia Pacific Computational Medicine and Drug Designing Software Market Size by Application (2017-2022) & (US$ Million)
    Table 46. Asia Pacific Computational Medicine and Drug Designing Software Market Size by Application (2023-2028) & (US$ Million)
    Table 47. Asia Pacific Computational Medicine and Drug Designing Software Market Size by Region (2017-2022) & (US$ Million)
    Table 48. Asia Pacific Computational Medicine and Drug Designing Software Market Size by Region (2023-2028) & (US$ Million)
    Table 49. Latin America Computational Medicine and Drug Designing Software Market Size by Type (2017-2022) & (US$ Million)
    Table 50. Latin America Computational Medicine and Drug Designing Software Market Size by Type (2023-2028) & (US$ Million)
    Table 51. Latin America Computational Medicine and Drug Designing Software Market Size by Application (2017-2022) & (US$ Million)
    Table 52. Latin America Computational Medicine and Drug Designing Software Market Size by Application (2023-2028) & (US$ Million)
    Table 53. Latin America Computational Medicine and Drug Designing Software Market Size by Country (2017-2022) & (US$ Million)
    Table 54. Latin America Computational Medicine and Drug Designing Software Market Size by Country (2023-2028) & (US$ Million)
    Table 55. Middle East and Africa Computational Medicine and Drug Designing Software Market Size by Type (2017-2022) & (US$ Million)
    Table 56. Middle East and Africa Computational Medicine and Drug Designing Software Market Size by Type (2023-2028) & (US$ Million)
    Table 57. Middle East and Africa Computational Medicine and Drug Designing Software Market Size by Application (2017-2022) & (US$ Million)
    Table 58. Middle East and Africa Computational Medicine and Drug Designing Software Market Size by Application (2023-2028) & (US$ Million)
    Table 59. Middle East and Africa Computational Medicine and Drug Designing Software Market Size by Country (2017-2022) & (US$ Million)
    Table 60. Middle East and Africa Computational Medicine and Drug Designing Software Market Size by Country (2023-2028) & (US$ Million)
    Table 61. Entelos Company Details
    Table 62. Entelos Business Overview
    Table 63. Entelos Computational Medicine and Drug Designing Software Product
    Table 64. Entelos Revenue in Computational Medicine and Drug Designing Software Business (2017-2022) & (US$ Million)
    Table 65. Entelos Recent Developments
    Table 66. Crown Bioscience Company Details
    Table 67. Crown Bioscience Business Overview
    Table 68. Crown Bioscience Computational Medicine and Drug Designing Software Product
    Table 69. Crown Bioscience Revenue in Computational Medicine and Drug Designing Software Business (2017-2022) & (US$ Million)
    Table 70. Crown Bioscience Recent Developments
    Table 71. Chemical Computing Group Company Details
    Table 72. Chemical Computing Group Business Overview
    Table 73. Chemical Computing Group Computational Medicine and Drug Designing Software Product
    Table 74. Chemical Computing Group Revenue in Computational Medicine and Drug Designing Software Business (2017-2022) & (US$ Million)
    Table 75. Chemical Computing Group Recent Developments
    Table 76. Nimbus Therapeutics Company Details
    Table 77. Nimbus Therapeutics Business Overview
    Table 78. Nimbus Therapeutics Computational Medicine and Drug Designing Software Product
    Table 79. Nimbus Therapeutics Revenue in Computational Medicine and Drug Designing Software Business (2017-2022) & (US$ Million)
    Table 80. Nimbus Therapeutics Recent Developments
    Table 81. Schrodinger Company Details
    Table 82. Schrodinger Business Overview
    Table 83. Schrodinger Computational Medicine and Drug Designing Software Product
    Table 84. Schrodinger Revenue in Computational Medicine and Drug Designing Software Business (2017-2022) & (US$ Million)
    Table 85. Schrodinger Recent Developments
    Table 86. Dassault Systemes Company Details
    Table 87. Dassault Systemes Business Overview
    Table 88. Dassault Systemes Computational Medicine and Drug Designing Software Product
    Table 89. Dassault Systemes Revenue in Computational Medicine and Drug Designing Software Business (2017-2022) & (US$ Million)
    Table 90. Dassault Systemes Recent Developments
    Table 91. Genedata Company Details
    Table 92. Genedata Business Overview
    Table 93. Genedata Computational Medicine and Drug Designing Software Product
    Table 94. Genedata Revenue in Computational Medicine and Drug Designing Software Business (2017-2022) & (US$ Million)
    Table 95. Genedata Recent Developments
    Table 96. Biognos Company Details
    Table 97. Biognos Business Overview
    Table 98. Biognos Computational Medicine and Drug Designing Software Product
    Table 99. Biognos Revenue in Computational Medicine and Drug Designing Software Business (2017-2022) & (US$ Million)
    Table 100. Biognos Recent Developments
    Table 101. Leadscope Company Details
    Table 102. Leadscope Business Overview
    Table 103. Leadscope Computational Medicine and Drug Designing Software Product
    Table 104. Leadscope Revenue in Computational Medicine and Drug Designing Software Business (2017-2022) & (US$ Million)
    Table 105. Leadscope Recent Developments
    Table 106. Rhenovia Pharma Limited Company Details
    Table 107. Rhenovia Pharma Limited Business Overview
    Table 108. Rhenovia Pharma Limited Computational Medicine and Drug Designing Software Product
    Table 109. Rhenovia Pharma Limited Revenue in Computational Medicine and Drug Designing Software Business (2017-2022) & (US$ Million)
    Table 110. Rhenovia Pharma Limited Recent Developments
    Table 111. Compugen Company Details
    Table 112. Compugen Business Overview
    Table 113. Compugen Computational Medicine and Drug Designing Software Product
    Table 114. Compugen Revenue in Computational Medicine and Drug Designing Software Business (2017-2022) & (US$ Million)
    Table 115. Compugen Recent Developments
    Table 116. Certara LP Company Details
    Table 117. Certara LP Business Overview
    Table 118. Certara LP Computational Medicine and Drug Designing Software Product
    Table 119. Certara LP Revenue in Computational Medicine and Drug Designing Software Business (2017-2022) & (US$ Million)
    Table 120. Certara LP Recent Developments
    Table 121. Prosarix Company Details
    Table 122. Prosarix Business Overview
    Table 123. Prosarix Computational Medicine and Drug Designing Software Product
    Table 124. Prosarix Revenue in Computational Medicine and Drug Designing Software Business (2017-2022) & (US$ Million)
    Table 125. Prosarix Recent Developments
    Table 126. Simulations Plus Company Details
    Table 127. Simulations Plus Business Overview
    Table 128. Simulations Plus Computational Medicine and Drug Designing Software Product
    Table 129. Simulations Plus Revenue in Computational Medicine and Drug Designing Software Business (2017-2022) & (US$ Million)
    Table 130. Simulations Plus Recent Developments
    Table 131. Strand Life Sciences Company Details
    Table 132. Strand Life Sciences Business Overview
    Table 133. Strand Life Sciences Computational Medicine and Drug Designing Software Product
    Table 134. Strand Life Sciences Revenue in Computational Medicine and Drug Designing Software Business (2017-2022) & (US$ Million)
    Table 135. Strand Life Sciences Recent Developments
    Table 136. Research Programs/Design for This Report
    Table 137. Key Data Information from Secondary Sources
    Table 138. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Computational Medicine and Drug Designing Software Market Share by Type: 2021 VS 2028
    Figure 2. Cloud-based Features
    Figure 3. On-premise Features
    Figure 4. Global Computational Medicine and Drug Designing Software Market Share by Application: 2021 VS 2028
    Figure 5. Drug Discovery and Development Case Studies
    Figure 6. Computational Physiological Medicine Case Studies
    Figure 7. Disease Modeling Case Studies
    Figure 8. Medical Imaging Case Studies
    Figure 9. Predictive Analysis of Drug Targets Case Studies
    Figure 10. Computational Medicine and Drug Designing Software Report Years Considered
    Figure 11. Global Computational Medicine and Drug Designing Software Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 12. Global Computational Medicine and Drug Designing Software Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 13. Global Computational Medicine and Drug Designing Software Market Share by Region: 2021 VS 2028
    Figure 14. Global Computational Medicine and Drug Designing Software Market Share by Players in 2021
    Figure 15. Global Top Computational Medicine and Drug Designing Software Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Computational Medicine and Drug Designing Software as of 2021)
    Figure 16. The Top 10 and 5 Players Market Share by Computational Medicine and Drug Designing Software Revenue in 2021
    Figure 17. North America Computational Medicine and Drug Designing Software Market Size YoY (2017-2028) & (US$ Million)
    Figure 18. North America Computational Medicine and Drug Designing Software Market Size Market Share by Type (2017-2028)
    Figure 19. North America Computational Medicine and Drug Designing Software Market Size Market Share by Application (2017-2028)
    Figure 20. North America Computational Medicine and Drug Designing Software Market Size Share by Country (2017-2028)
    Figure 21. United States Computational Medicine and Drug Designing Software Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Canada Computational Medicine and Drug Designing Software Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. Europe Computational Medicine and Drug Designing Software Market Size YoY (2017-2028) & (US$ Million)
    Figure 24. Europe Computational Medicine and Drug Designing Software Market Size Market Share by Type (2017-2028)
    Figure 25. Europe Computational Medicine and Drug Designing Software Market Size Market Share by Application (2017-2028)
    Figure 26. Europe Computational Medicine and Drug Designing Software Market Size Share by Country (2017-2028)
    Figure 27. Germany Computational Medicine and Drug Designing Software Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. France Computational Medicine and Drug Designing Software Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. U.K. Computational Medicine and Drug Designing Software Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Italy Computational Medicine and Drug Designing Software Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Russia Computational Medicine and Drug Designing Software Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Nordic Countries Computational Medicine and Drug Designing Software Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Asia-Pacific Computational Medicine and Drug Designing Software Market Size YoY (2017-2028) & (US$ Million)
    Figure 34. Asia Pacific Computational Medicine and Drug Designing Software Market Size Market Share by Type (2017-2028)
    Figure 35. Asia Pacific Computational Medicine and Drug Designing Software Market Size Market Share by Application (2017-2028)
    Figure 36. Asia Pacific Computational Medicine and Drug Designing Software Market Size Share by Region (2017-2028)
    Figure 37. China Computational Medicine and Drug Designing Software Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Japan Computational Medicine and Drug Designing Software Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. South Korea Computational Medicine and Drug Designing Software Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Southeast Asia Computational Medicine and Drug Designing Software Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. India Computational Medicine and Drug Designing Software Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Australia Computational Medicine and Drug Designing Software Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
    Figure 43. Latin America Computational Medicine and Drug Designing Software Market Size YoY (2017-2028) & (US$ Million)
    Figure 44. Latin America Computational Medicine and Drug Designing Software Market Size Market Share by Type (2017-2028)
    Figure 45. Latin America Computational Medicine and Drug Designing Software Market Size Market Share by Application (2017-2028)
    Figure 46. Latin America Computational Medicine and Drug Designing Software Market Size Share by Country (2017-2028)
    Figure 47. Mexico Computational Medicine and Drug Designing Software Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 48. Brazil Computational Medicine and Drug Designing Software Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 49. Middle East & Africa Computational Medicine and Drug Designing Software Market Size YoY (2017-2028) & (US$ Million)
    Figure 50. Middle East and Africa Computational Medicine and Drug Designing Software Market Size Market Share by Type (2017-2028)
    Figure 51. Middle East and Africa Computational Medicine and Drug Designing Software Market Size Market Share by Application (2017-2028)
    Figure 52. Middle East and Africa Computational Medicine and Drug Designing Software Market Size Share by Country (2017-2028)
    Figure 53. Turkey Computational Medicine and Drug Designing Software Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 54. Saudi Arabia Computational Medicine and Drug Designing Software Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 55. UAE Computational Medicine and Drug Designing Software Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 56. Entelos Revenue Growth Rate in Computational Medicine and Drug Designing Software Business (2017-2022)
    Figure 57. Crown Bioscience Revenue Growth Rate in Computational Medicine and Drug Designing Software Business (2017-2022)
    Figure 58. Chemical Computing Group Revenue Growth Rate in Computational Medicine and Drug Designing Software Business (2017-2022)
    Figure 59. Nimbus Therapeutics Revenue Growth Rate in Computational Medicine and Drug Designing Software Business (2017-2022)
    Figure 60. Schrodinger Revenue Growth Rate in Computational Medicine and Drug Designing Software Business (2017-2022)
    Figure 61. Dassault Systemes Revenue Growth Rate in Computational Medicine and Drug Designing Software Business (2017-2022)
    Figure 62. Genedata Revenue Growth Rate in Computational Medicine and Drug Designing Software Business (2017-2022)
    Figure 63. Biognos Revenue Growth Rate in Computational Medicine and Drug Designing Software Business (2017-2022)
    Figure 64. Leadscope Revenue Growth Rate in Computational Medicine and Drug Designing Software Business (2017-2022)
    Figure 65. Rhenovia Pharma Limited Revenue Growth Rate in Computational Medicine and Drug Designing Software Business (2017-2022)
    Figure 66. Compugen Revenue Growth Rate in Computational Medicine and Drug Designing Software Business (2017-2022)
    Figure 67. Certara LP Revenue Growth Rate in Computational Medicine and Drug Designing Software Business (2017-2022)
    Figure 68. Prosarix Revenue Growth Rate in Computational Medicine and Drug Designing Software Business (2017-2022)
    Figure 69. Simulations Plus Revenue Growth Rate in Computational Medicine and Drug Designing Software Business (2017-2022)
    Figure 70. Strand Life Sciences Revenue Growth Rate in Computational Medicine and Drug Designing Software Business (2017-2022)
    Figure 71. Bottom-up and Top-down Approaches for This Report
    Figure 72. Data Triangulation
    Figure 73. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Entelos
Crown Bioscience
Chemical Computing Group
Nimbus Therapeutics
Schrodinger
Dassault Systemes
Genedata
Biognos
Leadscope
Rhenovia Pharma Limited
Compugen
Certara LP
Prosarix
Simulations Plus
Strand Life Sciences
Frequently Asked Questions
Computational Medicine and Drug Designing Software report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Computational Medicine and Drug Designing Software report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Computational Medicine and Drug Designing Software report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Aluminum Radiator

The heat dissipation of aluminium is better, the characteristic of energy-saving is very apparent ... Read More